Concepedia

Publication | Open Access

Randomised clinical trial: tegoprazan, a novel potassium‐competitive acid blocker, or lansoprazole in the treatment of gastric ulcer

78

Citations

9

References

2020

Year

Abstract

Tegoprazan 50 or 100 mg were not inferior to lansoprazole 30 mg once daily in the treatment of gastric ulcers.

References

YearCitations

Page 1